Safety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia.

Safety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia.

Item
http://www.wikidata.org/entity/Q31942452
Familial hypercholesterolemia: present and future managementOptimal lipid modification: the rationale for combination therapyEvaluation of efficacy and safety of fixed dose lovastatin and niacin(ER) combination in asian Indian dyslipidemic patients: a multicentric studyNew cholesterol guidelines, new treatment challenges.Atheroprotective lipoprotein effects of a niacin-simvastatin combination compared to low- and high-dose simvastatin monotherapy.Niacin-ER and lovastatin treatment of hypercholesterolemia and mixed dyslipidemia.New lipid-modifying therapies.Treating dyslipidemic patients with lipid-modifying and combination therapies.Prolonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS studyNiacin-ER/statin combination for the treatment of dyslipidemia: focus on low high-density lipoprotein cholesterol.Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease.Simvastatin: present and future perspectives.Simvastatin: two decades in a circle.Combination treatment with atorvastatin plus niacin provides effective control of complex dyslipidemias: a literature review.Can niacin slow the development of atherosclerosis in coronary artery disease patients already taking statins?Addition of extended-release niacin to statin therapy: effects on atherosclerotic progression.
P2860

Safety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia.

Item
http://www.wikidata.org/entity/Q31942452
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Safety and effectiveness of Ni ...... for treatment of dyslipidemia.
@ast
Safety and effectiveness of Ni ...... for treatment of dyslipidemia.
@en
type
label
Safety and effectiveness of Ni ...... for treatment of dyslipidemia.
@ast
Safety and effectiveness of Ni ...... for treatment of dyslipidemia.
@en
prefLabel
Safety and effectiveness of Ni ...... for treatment of dyslipidemia.
@ast
Safety and effectiveness of Ni ...... for treatment of dyslipidemia.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Safety and effectiveness of Ni ...... for treatment of dyslipidemia.
@en
P2093
P304
P31
P356
10.1016/S0002-9149(00)01410-7
P407
P433
P478
P577
P698
P921